v3.26.1
Consolidated Statements of Cash Flows - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash (used in) provided by: Operating activities:      
Net loss for the year $ (7,097) $ (1,039) $ (922)
Adjustments for:      
Current income tax expense 208 256 25
Amortization of property and equipment 494 438 434
Amortization of intangible assets 2,152 1,876 1,736
Share?based compensation 136 196 288
Write-down of inventories, net of recoveries 458 78 277
Finance income, net (122) (165) (65)
Unrealized foreign exchange loss 123 71 108
Change in the following:      
Accounts receivable 227 150 760
Inventories 109 (207) (31)
Prepaid expenses (204) 237 (26)
Other assets 0 (18) 0
Accounts payable and accrued liabilities 2,948 (494) (236)
Interest received (paid), net 188 175 48
Income taxes paid, net (180) (177) (61)
Royalties paid 0 0 (256)
Cash flows from operating activities (560) 1,377 2,079
Investing activities:      
Acquisition of intangible assets 0 (739) (270)
Acquisition of Gateway Pharmacy (542)    
Acquisition of West Olympia Pharmacy (1,500) 0 0
Cash used in investing activities (2,042) (739) (270)
Financing activities:      
Repayment of lease liability (415) (370) (353)
Stock options exercised 0 0 56
Cash used in financing activities (415) (370) (297)
Foreign exchange gain (loss) on cash held in foreign currency (339) 554 0
Increase in cash and cash equivalents (3,356) 822 1,512
Cash and cash equivalents, beginning of period 7,191 6,369 4,857
Cash and cash equivalents, end of year $ 3,835 $ 7,191 $ 6,369